Novel Coronavirus Infection Completed Phase 2 Trials for Lopinavir (DB01601)

IndicationStatusPhase
DBCOND0126502 (Novel Coronavirus Infection)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04276688Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV TreatmentTreatment